Pharma Journalist 8962 posts 0 comments

Novartis announced that the US Food and Drug Administration (FDA) accepted the company's Biologics License Application (BLA) for brolucizumab (RTH258) for the treatment of wet…
Read More...

Alnylam Pharmaceuticals announced that the Company has initiated ILLUMINATE-B, a global Phase 3 pediatric study of lumasiran, an investigational, subcutaneously administered RNAi…
Read More...

San Diego-based Allele Biotechnology and Pharmaceuticals, Inc., officially announced a joint research and development agreement with South Korea’s SCM Lifescience Co., Ltd., for the…
Read More...

DNAnexus, Inc., and the not-for-profit Sutter Health network announced the first large-scale clinico-genomic multiple sclerosis (MS) research study conducted by a leading healthcare…
Read More...

Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, announces it has entered a public-private partnership with the…
Read More...

Pulmatrix and Cipla Technologies announced their entry into a Definitive Agreement for the co-development and commercialization of Pulmazole (PUR1900) – an inhaled iSPERSE formulation…
Read More...

Boehringer Ingelheim has acquired a minority stake in SoundTalks NV, a Belgian company. SoundTalks NV has developed a digital monitoring tool that seeks to improve the healthcare of…
Read More...

Catalent and Paragon Bioservices announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion. “Paragon’s unparalleled expertise…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that it has entered into a definitive agreement to acquire a portfolio of 42 approved, non-marketed Abbreviated New Drug Applications (ANDAs) in…
Read More...

Bristol-Myers Squibb Company announced that its shareholders voted to approve the issuance of shares of Bristol-Myers Squibb common stock in connection with the Company’s pending merger…
Read More...